{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:29:24Z","timestamp":1740126564387,"version":"3.37.3"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,7]]},"DOI":"10.1093\/eurheartj\/ehaa1063","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:25:28Z","timestamp":1611015928000},"page":"139-142","source":"Crossref","is-referenced-by-count":2,"title":["Machine learning-guided phenotyping of dilated cardiomyopathy and treatment of heart failure by antisense oligonucleotides: the future has begun"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9404-8846","authenticated-orcid":false,"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"2021012009033184300_ehaa1063-B1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2021012009033184300_ehaa1063-B2","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1056\/NEJMoa025039","article-title":"Adherence to a Mediterranean diet and survival in a Greek population. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D","volume":"348","author":"deKoning","year":"2003","journal-title":"N Engl J Med"},{"key":"2021012009033184300_ehaa1063-B3","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","article-title":"Therapeutic perspectives in hypertension: novel means for renin\u2013angiotensin\u2013aldosterone system modulation and emerging device-based approaches","volume":"32","author":"Unger","year":"2011","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B4","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B6","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/eurheartj\/ehx808","article-title":"Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias","volume":"39","author":"Verdonschot","year":"2018","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2021012009033184300_ehaa1063-B9","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1093\/eurheartj\/ehy712","article-title":"Novel endotypes in heart failure: effects on guideline-directed medical therapy","volume":"39","author":"Tromp","year":"2018","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/eurheartj\/ehaa841","article-title":"Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences","volume":"42","author":"Verdonschot","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/eurheartj\/ehaa869","article-title":"Personalized medicine for dilated cardiomyopathy","volume":"42","author":"Elliott","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B12","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1093\/eurheartj\/ehaa229","article-title":"From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases","volume":"41","author":"Landmesser","year":"2020","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehaa967","article-title":"Antagonism of miRNA in heart failure: first evidence in human","volume":"42","author":"Baker","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur Heart J"},{"key":"2021012009033184300_ehaa1063-B16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/eurheartj\/ehaa870","article-title":"CDR132L: another brick in the wall towards the use of miRNAs to treat cardiovascular disease","volume":"42","author":"Devaux","year":"2021","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/2\/139\/35926288\/ehaa1063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/2\/139\/35926288\/ehaa1063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:41:12Z","timestamp":1611153672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/2\/139\/6103992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1,18]]},"published-print":{"date-parts":[[2021,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1063","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"type":"print","value":"0195-668X"},{"type":"electronic","value":"1522-9645"}],"subject":[],"published-other":{"date-parts":[[2021,1,7]]},"published":{"date-parts":[[2021,1,7]]}}}